Latest Breaking News On - Pardes bioscience - Page 1 : comparemela.com

Moore Kuehn Encourages FRGI, VRTV, SCU, and PRDS Investors to Contact Law Firm

Moore Kuehn Encourages FRGI, VRTV, SCU, and PRDS Investors to Contact Law Firm
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMoore kuehnJustin kuehnPardes bioscienceVeritiv corporationFiesta restaurant groupPardes bioscience incFiesta restaurant group incSculptor capital management incWall streetNew york cityRestaurant groupAuthentic restaurantCapital managementSculptor capital management

Moore Kuehn Encourages FRGI, VRTV, SCU, and PRDS Investors

NEW YORK, Aug. 08, 2023 (GLOBE NEWSWIRE) Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York.

New yorkUnited statesPardes bioscienceJustin kuehnMoore kuehnSculptor capital management incFiesta restaurant groupFiesta restaurant group incPardes bioscience incVeritiv corporationWall streetNew york cityRestaurant groupAuthentic restaurantCapital managementSculptor capital management

Moore Kuehn Encourages PRDS, AMNB, NLTX, and SCU Investors to Contact Law Firm

/PRNewswire/ Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential.

New yorkUnited statesMoore kuehnJustin kuehnPrnewswire moore kuehnPardes bioscienceAmerican national banksharesAmerican national bankshares incAtlantic unionAtlantic union banksharesNeoleukin therapeutics incPardes bioscience incSculptor capital management incWall streetNew york cityNational bankshares

Pardes Biosciences Reports First Quarter 2023 Financial

CARLSBAD, Calif., May 05, 2023 (GLOBE NEWSWIRE) Pardes Biosciences, Inc. (NASDAQ: PRDS) today reported financial results for the first quarter ended.

Pardes bioscienceThomasg wiggansPardes biosciencesPardes biosciences incExchange commissionChief executive officerParde quarterly reportPardes bioscience investorsPrivate securities litigation reform actParde annual reportQuarterly reportFinancial informationMonths ended marchNasdaq prdsPardes biosciences

Pardes Biosciences (NASDAQ:PRDS) Downgraded to Hold at Jefferies Financial Group

Jefferies Financial Group lowered shares of Pardes Biosciences (NASDAQ:PRDS – Get Rating) from a buy rating to a hold rating in a research note issued to investors on Monday, The Fly reports. Jefferies Financial Group also issued estimates for Pardes Biosciences’ Q2 2023 earnings at ($0.36) EPS, Q3 2023 earnings at ($0.27) EPS, Q4 2023 […]

United statesPardes biosciencesPardes biosciencePardes biosciences incJpmorgan chase coVirtu financialSecurities exchange commissionJackson square capitalAmerican international group incJefferies financial groupGet ratingFinancial groupExchange commissionStreet groupInternational groupPardes biosciences daily